Tschimganine
Tschimganine has been studied in 2 papers since 2018: none in people yet, 2 in cells. No study of it in people or animals has been published yet. The newest paper, Apr 14, 2022: “Tschimganine has different targets for chronological lifespan extension and growth inhibition in fission yeast”.
See all 2 papers on tschimganine
At a glance
The findings reach worms or flies, none yet in people. 1 lab in 1 country.
None of its findings points the other way.
- 1 lab in 1 country
- Funders: Japan Society for the Promotion of Science and 2 more
- Cells2
What did studies of tschimganine find?
3Studies of tschimganine measured 3 outcomes: lifespan, cell growth and sty1 pathway.
Lifespan
upin fission yeast cells2
2 studies
Lifespan
upin fission yeast cells2
Tschimganine extends lifespan in fission yeast cells.
“Tschimganine inhibits growth and extends the chronological lifespan in Schizosaccharomyces pombe.”
Cells
Bioscience, biotechnology, and biochemistry
Tschimganine extends lifespan in fission yeast cells.
“tschimganine led to the extension of CLS”
Cells
Genes to cells : devoted to molecular & cellular mechanisms
Cell growth
downin fission yeast cells1
1 study
Cell growth
downin fission yeast cells1
Tschimganine inhibits cell growth in fission yeast cells.
“Tschimganine inhibits growth and extends the chronological lifespan in Schizosaccharomyces pombe.”
Cells
Bioscience, biotechnology, and biochemistry
Sty1 pathway
upin fission yeast cells1
1 study
Sty1 pathway
upin fission yeast cells1
Tschimganine activates sty1 pathway in fission yeast cells.
“tschimganine and its derivatives extend CLS by activating the Sty1 pathway in fission yeast”
Cells
Genes to cells : devoted to molecular & cellular mechanisms